GlassScriptPhysician profile
Jennifer R Laborde
NPI 1184984130
$514.18
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $445 · 2022: $69.68.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $137.39 | 2021-2022 | |
| Boston Scientific Corporation | $126.13 | 2021 | |
| Nevro Corp. | $58.53 | 2021 | |
| Collegium Pharmaceutical, INC. | $53.31 | 2021-2022 | |
| Si-Bone, INC. | $35.45 | 2021 | |
| Abbvie INC. | $22.06 | 2021 | |
| Bioventus LLC | $20.58 | 2021 | |
| Biogen, INC. | $19.56 | 2021 | |
| Scilex Pharmaceuticals INC. | $15.12 | 2021 | |
| Virtus Pharmaceuticals LLC | $13.71 | 2021 | |
| Biodelivery Sciences International, INC. | $12.34 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Laborde listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.